Wound News and Research

RSS

ARIAD temporarily suspends commercial distribution of Iclusig drug in US

ARIAD Pharmaceuticals, Inc. today announced that it is temporarily suspending the marketing and commercial distribution of Iclusig® (ponatinib), a treatment for patients with resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL), in the United States, while it continues to negotiate updates to the U.S. prescribing information for Iclusig and implementation of a risk mitigation strategy.

31 Oct 2013

Interaction between fat cells and bacterial toxins can lead to chronic inflammation

Making fat cells immortal might seem like a bad idea to most people, but for a team of University of Iowa scientists it was the ideal way to study how the interaction between bacteria and fat cells might contribute to diabetes.

31 Oct 2013

Protego develops sternal device for cardiac surgery with start-up investment from MRCF

Protego Medical Pty Ltd, an early stage medical technology company developing a medical device for sternal protection during cardiac surgery, was launched today with AU$2M start-up financing from Australia’s Medical Research Commercialisation Fund (MRCF). At the same time, the Company announced the appointment of Pablo Solis as CEO.

31 Oct 2013

MiMedx Group reports record revenue in third quarter 2013

MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the quarter ended September 30, 2013.

30 Oct 2013

REDDSTAR plenary meeting to be held in Berlin on Nov 5 and 6

'Diabetes- can stem cells help?' is a free, public event that will be held on Monday, 4 November 2013 from 19:00- 20:30 at The Ruin located within the Berlin Museum of Medical History, Charité. Diabetes and stem cell researchers from around Europe will assemble for a REDDSTAR plenary meeting hosted by Charité in Berlin on November 5 and 6th.

30 Oct 2013

Dermatologists provide list of specific treatments, procedures not required for medical care

The American Academy of Dermatology today released its list of specific treatments and procedures related to skin health and care that are not always necessary.

29 Oct 2013

Research findings open up possibility for developing potent anti-clotting drugs

Researchers at the University of Illinois at Chicago have discovered a molecular switch that causes small, beneficial clots that stop bleeding to enlarge further during wound healing. By blocking this switch in lab mice, the researchers prevented small clots from growing -- a process that can pose a danger in humans -- while preserving their ability to staunch bleeding

29 Oct 2013

APR's Nexodyn receives European CE approval

APR announces the grant of the European CE approval of Nexodyn, a newly developed innovative product intended for use in a variety of wound conditions such as acute wounds, burns and advanced ulcers including venous and pressure ulcers and diabetic foot ulcers.

28 Oct 2013

Findings bring scientists closer to establishing regenerative therapies for humans

Cells triggering tissue regeneration that are taken from one limb and grafted onto another acquire the molecular "fingerprint," or identity, of their new location, UC Irvine developmental biologists have discovered.

25 Oct 2013

Rice University research reveals 3-way genetic switch for cancer metastasis

Cancer researchers from Rice University have deciphered the operating principles of a genetic switch that cancer cells use to decide when to metastasize and invade other parts of the body. The study found that the on-off switch's dynamics also allows a third choice that lies somewhere between "on" and "off." The extra setting both explains previously confusing experimental results and opens the door to new avenues of cancer treatment.

25 Oct 2013

Republicans see new political battleground because of bumpy health exchange rollout

Though the health law came through the most recent budget battle unscathed, its opponents view the problems with the website as a potential opportunity -- both in terms of the fight to derail the law and as an election issue for the upcoming campaign cycle.

22 Oct 2013

Breast milk may protect babies from acquiring HIV infection, say researchers

A substance in breast milk that neutralizes HIV and may protect babies from acquiring HIV from their infected mothers has been identified for the first time by researchers at Duke Medicine.

22 Oct 2013

First Edition: October 21, 2013

Today's headlines include the latest reports about how the Obama administration plans to make the necessary fixes in the health law's online insurance marketplace.

21 Oct 2013

Clarified role of signal-relay proteins may help explain spread of cancer

Cell biologists at The Johns Hopkins University have teased apart two integral components of the machinery that causes cells to move. Their discovery shows that cellular projections, which act as hands to help a cell "crawl," are apparently always initiated by a network of message-relaying proteins inside the cell.

21 Oct 2013

Valley Presbyterian Hospital doc awarded 2013 Achievement Award in Diabetic Limb Salvage

George Andros, MD, Founder and Medical Director of the Amputation Prevention Center at Valley Presbyterian Hospital, was honored with the MedStar Georgetown 2013 Distinguished Achievement Award in Diabetic Limb Salvage.

19 Oct 2013

Study shows narrow-spectrum UV light reduces surgical infections without damaging tissue

Despite major efforts to keep operating rooms sterile, surgical wound infections remain a serious and stubborn problem, killing up to 8,200 patients a year in the U.S. A study by Columbia University Medical Center (CUMC) researchers suggests that narrow-spectrum ultraviolet (UV) light could dramatically reduce such infections without damaging human tissue.

17 Oct 2013

New type of antibiotic kills multidrug-resistant germ common to health care settings

A new type of antibiotic called a PPMO, which works by blocking genes essential for bacterial reproduction, successfully killed a multidrug-resistant germ common to health care settings, UT Southwestern Medical Center researchers report.

16 Oct 2013

Rates of hospital-acquired bedsores not accurate tool for comparing hospital quality, says report

The data Medicare uses to publicly report hospital rates of patients developing pressure ulcers (or bedsores) is not an accurate source for comparing hospitals on how well they prevent the condition, says a new University of Michigan study.

15 Oct 2013

Misonix terminates Product License and Distribution Agreement with PuriCore

Misonix, Inc., a surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic surgery, neurosurgery, laparoscopic surgery and other surgical applications, announced today that Misonix terminated its Product License and Distribution Agreement with PuriCore, Inc. for the sale of PuriCore's Vashe System.

12 Oct 2013

High voltage, short pulsed electric fields destroy cells in skin tissue, lead to scarless tissue regeneration

High voltage, short pulsed electric fields, used for disinfection and solid tumor destruction, selectively damage cell membranes, while preserving overall tissue structure, a phenomenon that may be a key factor in scarless tissue regeneration.

11 Oct 2013

Wound News and Research

ARIAD temporarily suspends commercial distribution of Iclusig drug in US

Interaction between fat cells and bacterial toxins can lead to chronic inflammation

Protego develops sternal device for cardiac surgery with start-up investment from MRCF

MiMedx Group reports record revenue in third quarter 2013

REDDSTAR plenary meeting to be held in Berlin on Nov 5 and 6

Dermatologists provide list of specific treatments, procedures not required for medical care

Research findings open up possibility for developing potent anti-clotting drugs

APR's Nexodyn receives European CE approval

Findings bring scientists closer to establishing regenerative therapies for humans

Rice University research reveals 3-way genetic switch for cancer metastasis

Republicans see new political battleground because of bumpy health exchange rollout

Breast milk may protect babies from acquiring HIV infection, say researchers

First Edition: October 21, 2013

Clarified role of signal-relay proteins may help explain spread of cancer

Valley Presbyterian Hospital doc awarded 2013 Achievement Award in Diabetic Limb Salvage

Study shows narrow-spectrum UV light reduces surgical infections without damaging tissue

New type of antibiotic kills multidrug-resistant germ common to health care settings

Rates of hospital-acquired bedsores not accurate tool for comparing hospital quality, says report

Misonix terminates Product License and Distribution Agreement with PuriCore

High voltage, short pulsed electric fields destroy cells in skin tissue, lead to scarless tissue regeneration

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News